Similar articles for PMID: 32444368

Year	Number of Results
2005	2
2006	1
2008	1
2010	2
2011	3
2012	2
2013	9
2014	6
2015	14
2016	12
2017	10
2018	13
2019	11
2020	17
2021	12
2024	0

1

Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy.

Strosberg JR, Al-Toubah T, Pellè E, Smith J, Haider M, Hutchinson T, Fleming JB, El-Haddad G. Strosberg JR, et al. J Nucl Med. 2021 Jan;62(1):69-72. doi: 10.2967/jnumed.120.242875. Epub 2020 May 22. J Nucl Med. 2021. PMID: 32444368 Free article.

2

Long-term results and tolerability of tandem peptide receptor radionuclide therapy with ⁹⁰Y/¹⁷⁷Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.

Kunikowska J, Pawlak D, Bąk MI, Kos-Kudła B, Mikołajczak R, Królicki L. Kunikowska J, et al. Ann Nucl Med. 2017 Jun;31(5):347-356. doi: 10.1007/s12149-017-1163-6. Epub 2017 Mar 18. Ann Nucl Med. 2017. PMID: 28316066

3

177Lu-DOTATATE PRRT in Patients with Metastatic Neuroendocrine Tumor and a Single Functioning Kidney: Tolerability and Effect on Renal Function.

Ranade R, Basu S. Ranade R, et al. J Nucl Med Technol. 2016 Jun;44(2):65-9. doi: 10.2967/jnmt.115.168146. Epub 2016 Feb 4. J Nucl Med Technol. 2016. PMID: 26848166 Free article.

4

Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors.

Hamiditabar M, Ali M, Bolek L, Vahdati G, Tworowska I, Delpassand ES. Hamiditabar M, et al. Clin Nucl Med. 2017 Nov;42(11):822-828. doi: 10.1097/RLU.0000000000001818. Clin Nucl Med. 2017. PMID: 28832377

5

Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Bergsma H, van Lom K, Raaijmakers MHGP, Konijnenberg M, Kam BLBLR, Teunissen JJM, de Herder WW, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. J Nucl Med. 2018 Mar;59(3):452-458. doi: 10.2967/jnumed.117.189712. Epub 2017 Aug 3. J Nucl Med. 2018. PMID: 28775205 Free article.

6

Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.

Ianniello A, Sansovini M, Severi S, Nicolini S, Grana CM, Massri K, Bongiovanni A, Antonuzzo L, Di Iorio V, Sarnelli A, Caroli P, Monti M, Scarpi E, Paganelli G. Ianniello A, et al. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1040-6. doi: 10.1007/s00259-015-3262-8. Epub 2015 Nov 27. Eur J Nucl Med Mol Imaging. 2016. PMID: 26611427 Clinical Trial.

7

¹³¹I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy.

Parghane RV, Talole S, Basu S. Parghane RV, et al. Ann Nucl Med. 2021 Jan;35(1):92-101. doi: 10.1007/s12149-020-01541-z. Epub 2020 Nov 1. Ann Nucl Med. 2021. PMID: 33135123

8

Renal and hematological toxicity in patients of neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-DOTATATE.

Gupta SK, Singla S, Bal C. Gupta SK, et al. Cancer Biother Radiopharm. 2012 Nov;27(9):593-9. doi: 10.1089/cbr.2012.1195. Epub 2012 Sep 25. Cancer Biother Radiopharm. 2012. PMID: 23009580

9

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Valkema R, Pauwels SA, Kvols LK, Kwekkeboom DJ, Jamar F, de Jong M, Barone R, Walrand S, Kooij PP, Bakker WH, Lasher J, Krenning EP. Valkema R, et al. J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S. J Nucl Med. 2005. PMID: 15653656 Free article. Clinical Trial.

10

In Vivo Instability of ¹⁷⁷Lu-DOTATATE During Peptide Receptor Radionuclide Therapy.

Lubberink M, Wilking H, Öst A, Ilan E, Sandström M, Andersson C, Fröss-Baron K, Velikyan I, Sundin A. Lubberink M, et al. J Nucl Med. 2020 Sep;61(9):1337-1340. doi: 10.2967/jnumed.119.237818. Epub 2020 Jan 31. J Nucl Med. 2020. PMID: 32005767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year